EU Pharma Reform: Negotiations Could See Patient Voice ‘Discarded,’ Warn Patient Groups

 
• By Eliza Slawther
  
Plans to include patients in EMA committees could be scrapped under the new pharma legislation reform, patient groups say (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU Pharma Legislation Reform

More from Pathways & Standards